Alzheimer's researchers say brain stimulation device may slow symptoms

Researchers have tested transcranial magnetic stimulation (TMS) to slow Alzheimer’s progression. TMS, a technique already used for depression, stimulates specific brain areas with magnetic pulses. In this study, it targeted networks in the brain tied to memory, aiming to help neurons reconnect in regions affected by Alzheimer’s. This approach offers a non-drug option to tackle symptoms, unlike traditional treatments that often have serious side effects.

In a small trial, 32 Alzheimer’s patients received weekly TMS sessions lasting 20 minutes. Compared to those in the placebo group, patients given TMS saw a 44% reduction in symptom worsening based on cognitive tests. Side effects were minimal, limited mostly to mild headaches and skin irritation. TMS also helped preserve patients' daily functioning, showing potential as a safe alternative to expensive antibody treatments.

Experts remain cautious due to the study's small scale and single location. Larger, multi-site trials are planned to validate the results and assess TMS’s effectiveness on a broader scale. If confirmed, TMS could become a helpful, low-risk treatment for managing Alzheimer’s, bringing hope for patients and caregivers alike.